PT -期刊文章盟戴尔芬Gourcerol AU - Arnaud Scherpereel盟Stephane Debeugny AU - Henri土耳其宫廷盟亚历克西斯b Cortot盟——让-雅克•拉菲特TI -相关性的一个广泛的手术后随访nonsmall细胞肺癌援助- DP - 2013年11月01 TA - 10.1183/09031936.00086712欧洲呼吸杂志》第六PG - 1357 - 1364 - 42 IP - 5 4099 - //www.qdcxjkg.com/content/42/5/1357.short 4100 - //www.qdcxjkg.com/content/42/5/1357.full所以欧元和J2013 11月01;42 AB -没有国际指导方针,一个适当的和具有成本效益的后续切除nonsmall细胞性肺癌(NSCLC)。我们回顾了非小细胞肺癌患者治疗手术后的结果。每三个月随访包括体格检查及胸部x线摄影,和胸部计算机断层扫描(CT)扫描,支气管镜检查,腹部超声、脑CT扫描和骨扫描每6个月为3年,每年在接下来的2年。预后因素和成本进行分析。中位总生存期的非小细胞肺癌手术后162例患者是38.5个月。复发发生在85年(52.5%),包括41个(48%)病人症状。无病生存之间类似的无症状的复发与患者有症状的患者(11.4和12个月;p = 0.41)。在体检中发现的复发是或47例(55.3%)患者的胸部x线摄影。 Curative-intent therapy was provided in 18 (41%) out of 44 patients with asymptomatic recurrence and in four (10%) out of 41 symptomatic cases (p=0.001). Median overall survival from time of recurrence was higher in asymptomatic patients than in symptomatic patients (15.5 versus 7.2 months; p=0.001). The cost per year of life gained was USD32 700 (€22 397). An extensive follow-up, with acceptable cost, may improve the outcome of patients with resected NSCLC through detection of asymptomatic recurrences; however, validation by prospective studies is required. An extensive follow-up, with acceptable cost, may improve the outcome of patients with resected NSCLC http://ow.ly/nUOez